March 20, 2017
Arix Bioscience, LDC, MPI, University of Leeds join to fight metabolic diseases
Arix Bioscience, the Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MPI), and the University of Leeds have signed agreement to develop new therapeutics for metabolic diseases based on the discoveries from these organisations.